Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-050460)

Filing Details

Accession Number:: 0001209191-22-050460
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-09-19 14:34:04
Reporting Period:: 2022-09-15

Accepted Time:: 2022-09-19 14:34:04
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1652724	Lucira Health Inc.	LHDX	In Vitro & In Vivo Diagnostic Substances (2835)	272491037

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1839384	T. Erik Engelson	C/O Lucira Health Inc. 1412 62Nd St Emeryville CA 94608	President And Chief Executive	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-09-15	20,000	$1.82	83,282	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	46,400	Indirect	See Footnotes
Common Stock	191,705	Indirect	See Footnotes

Footnotes

The shares are held by the Elizabeth North Engelson Trust, dated January 17, 2001, for which Mr. Engelson serves as trustee.
The shares are held by Epic Pacific, LLC, of which Mr. Engelson is a Member. Mr. Engelson disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.